Sopra Steria Group: 2026 Half-Year Financial Report Now Available

PARIS--(BUSINESS WIRE)-- Regulatory News:

Sopra Steria announces today that they have made available to the public and filed with the Autorité des Marchés Financiers (AMF) the half-yearly Financial Report at 30 June 2026.

It is made publicly available under the conditions set forth by existing regulations and can be found online at https://www.soprasteria.com/en/investors (under Investors/Financial Publications & Reports/Financial Reports).

This Half-Year Financial Report consists of the business review for the six-month period ended June 30, 2026, the condensed consolidated financial statements for the six-month period ended June 30, 2026, the Statutory Auditors’ review report on the half-yearly financial information and the statement of the persons responsible.

About Sopra Steria

Sopra Steria, a major tech player in Europe with 51,000 employees in nearly 30 countries, is recognised for its consulting, digital services and solutions. It helps its clients drive their digital transformation and obtain tangible and sustainable benefits. The Group provides end-to-end solutions to make large companies and organisations more competitive by combining in-depth knowledge of a wide range of business sectors and technologies with a collaborative approach. Sopra Steria places people at the heart of everything it does and is committed to putting digital to work for its clients in order to build a positive future for all. In 2025, the Group generated revenue of €5.6 billion.

The world is how we shape it

Sopra Steria (SOP) is listed on Euronext Paris (Compartment A) – ISIN: FR0000050809

For more information, visit us at www.soprasteria.com

Copyright © 2026 Sopra Steria. All rights reserved. Sopra Steria and its logo are registered trademarks of Sopra Steria.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260731590770/en/

Investor Relations
Olivier Psaume
[email protected]
+33 (0)6 17 64 29 39

Press Relations
Clémence Vermersch, Caroline Simon (Image 7)
[email protected], [email protected]
+33 (0)6 75 99 67 51

Source: Sopra Steria

You May Also Be Interested In

• Vitruvias Therapeutics, Inc. Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
• Eylsia Nicolas Continues Her Global Surge: New BookKard Release, Power Ace Radio Honors, and a Life Story Spanning Tennis Triumphs, Hollywood Turbulence, Academic Leadership, Patented Sound Technology
• Simply Good Foods Company Securities Fraud Class Action Result of Undisclosed Acquisition Failures and Over 27% Stock Decline - Investors May Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC